Published in BMC Neurol on April 28, 2009
Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients. PLoS One (2011) 1.03
Inflammation biomarkers and risk of all-cause mortality in the Reasons for Geographic And Racial Differences in Stroke cohort. Am J Epidemiol (2011) 0.97
C-reactive protein and hypertension. J Hum Hypertens (2013) 0.94
Effect of IMOD™ on the inflammatory process after acute ischemic stroke: a randomized clinical trial. Daru (2013) 0.87
C-reactive protein and long-term ischemic stroke prognosis. J Clin Neurosci (2013) 0.87
Elevation of serum CXCL16 level correlates well with atherosclerotic ischemic stroke. Arch Med Sci (2014) 0.84
Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome. Crit Care (2014) 0.82
Association between oxidative stress and outcome in different subtypes of acute ischemic stroke. Biomed Res Int (2014) 0.82
Serum YKL-40 levels correlate with infarct volume, stroke severity, and functional outcome in acute ischemic stroke patients. PLoS One (2012) 0.82
High sensitivity C-reactive protein levels in Acute Ischemic Stroke and subtypes: A study from a tertiary care center. Iran J Neurol (2013) 0.79
Is there a correlation between hs-CRP levels and functional outcome of Ischemic Stroke? Pak J Med Sci (2013) 0.78
Follow-up C-reactive protein level is more strongly associated with outcome in stroke patients than admission levels. Neurol Sci (2015) 0.78
Selenoprotein S expression in the rat brain following focal cerebral ischemia. Neurol Sci (2013) 0.77
Comparison of acute versus convalescent stage high-sensitivity C-Reactive protein level in predicting clinical outcome after acute ischemic stroke and impact of erythropoietin. J Transl Med (2012) 0.76
Biomarkers and functional outcomes from ischaemic cerebral events in women: a prospective cohort study. Eur J Neurol (2012) 0.76
Changes in the cellular immune system and circulating inflammatory markers of stroke patients. Oncotarget (2016) 0.75
Platelet microparticles: a biomarker for recanalization in rtPA-treated ischemic stroke patients. Ann Clin Transl Neurol (2017) 0.75
Reduction of the systemic inflammatory induced by acute cerebral infarction through ultra-early thrombolytic therapy. Exp Ther Med (2015) 0.75
Protein-energy malnutrition developing after global brain ischemia induces an atypical acute-phase response and hinders expression of GAP-43. PLoS One (2014) 0.75
Serum IL-33 Is a Novel Diagnostic and Prognostic Biomarker in Acute Ischemic Stroke. Aging Dis (2016) 0.75
The Relationship between C-Reactive Protein Level and Discharge Outcome in Patients with Acute Ischemic Stroke. Int J Environ Res Public Health (2016) 0.75
High-sensitivity C reactive protein as a predictor of inhospital mortality in patients with cardiovascular disease at an emergency department: a retrospective cohort study. BMJ Open (2017) 0.75
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23
Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet (1991) 12.30
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet (2007) 10.74
Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med (2008) 7.95
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ (2000) 6.10
Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation (1998) 4.89
Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol (1996) 3.82
Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out. Circulation (2006) 3.35
Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke (2004) 2.75
Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke (2001) 2.71
High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation (2006) 2.69
C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke (2001) 2.38
Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke (2006) 2.22
An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol (2003) 1.97
Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke (2002) 1.94
Inflammation and thrombosis: the clot thickens. Circulation (2001) 1.79
C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke (2003) 1.78
High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke. Arch Intern Med (2006) 1.73
C-reactive protein and outcome after ischemic stroke. Stroke (1999) 1.42
C-reactive protein and white blood cell count increases in the first 24 hours after acute stroke. Cerebrovasc Dis (2004) 1.19
Systemic complement activation following human acute ischaemic stroke. Clin Exp Immunol (2004) 1.16
C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study. Atherosclerosis (2007) 1.08
Prognostic role of C-reactive protein in very old patients with acute ischaemic stroke. J Intern Med (2005) 0.96
C-reactive protein is an indicator for fatal outcomes in first-time stroke patients. Med Sci Monit (2005) 0.90
Prognostic implications of admission inflammatory profile in acute ischemic neurological events. Acta Neurol Scand (2002) 0.85
Plasma levels of inflammatory C-reactive protein and interleukin-6 predict outcome in elderly patients with stroke. J Am Geriatr Soc (2004) 0.84
C-reactive protein (CRP) in cerebro-vascular events. Atherosclerosis (1999) 0.82
Early inflammatory response in ischemic stroke. Thromb Res (2001) 0.79
[C-reactive protein as an important prognostic marker for ischemic stroke]. Zhonghua Yu Fang Yi Xue Za Zhi (2003) 0.79
C-reactive protein, physical disability, and prognosis in very old patients with ischemic stroke. J Gerontol A Biol Sci Med Sci (2002) 0.77
[Diffusion-weighted MR in transient ischemic attacks]. Tidsskr Nor Laegeforen (2015) 3.21
[Patients with acute cerebral infarction admitted to stroke unit]. Tidsskr Nor Laegeforen (2011) 1.45
Effects of amiodarone and thoracic epidural analgesia on atrial fibrillation after coronary artery bypass grafting. J Cardiothorac Vasc Anesth (2004) 1.45
Migraine among Norwegian neurologists. Headache (2012) 1.42
[a woman with recurrence of venous and arterial thrombosis]. Tidsskr Nor Laegeforen (2011) 1.39
[Stroke neurology and interdisciplinarity]. Tidsskr Nor Laegeforen (2011) 1.38
Cerebral arterial vasospasm. Tidsskr Nor Laegeforen (2011) 1.38
Demographic and geographic vascular risk factor differences in European young adults with ischemic stroke: the 15 cities young stroke study. Stroke (2012) 1.20
Health-related quality of life among young adults with ischemic stroke on long-term follow-up. Stroke (2006) 1.18
Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study. Eur J Cancer Prev (2008) 1.18
Fatigue among stroke patients on long-term follow-up. The Bergen Stroke Study. J Neurol Sci (2011) 1.16
Fatigue at long-term follow-up in young adults with cerebral infarction. Cerebrovasc Dis (2005) 1.15
Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol (2002) 1.08
[Re: What is good treatment of acute stroke?]. Tidsskr Nor Laegeforen (2015) 1.07
European Stroke Organisation recommendations to establish a stroke unit and stroke center. Stroke (2013) 1.04
Occipital lobe infarctions are different. Vasc Health Risk Manag (2007) 1.02
The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke. BMC Neurol (2014) 1.02
Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993. Schizophr Res (2004) 1.00
Instrumental assessment of atopic eczema: validation of transepidermal water loss, stratum corneum hydration, erythema, scaling, and edema. J Am Acad Dermatol (2006) 0.97
Diffusion-weighted lesions in stroke patients with transient symptoms--where are they located? Cerebrovasc Dis (2014) 0.92
Serum albumin in ischemic stroke patients: the higher the better. The Bergen Stroke Study. Cerebrovasc Dis (2009) 0.91
Underfunding of stroke research: a Europe-wide problem. Stroke (2004) 0.90
The effects of fatigue, pain, and depression on quality of life in ischemic stroke patients: the Bergen Stroke Study. Vasc Health Risk Manag (2012) 0.89
The triad of pain, fatigue and depression in ischemic stroke patients: the Bergen Stroke Study. Cerebrovasc Dis (2012) 0.89
Risk factors and their impact on carotid intima-media thickness in young and middle-aged ischemic stroke patients and controls: the Norwegian Stroke in the Young Study. BMC Res Notes (2014) 0.88
Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study. BMC Neurol (2011) 0.87
Intracerebral hemorrhage in southern Norway--a hospital-based incidence study. Eur Neurol (2012) 0.87
Predictors for recanalization after intravenous thrombolysis in acute ischemic stroke. J Stroke Cerebrovasc Dis (2007) 0.86
The Norwegian Stroke in the Young Study (NOR-SYS): rationale and design. BMC Neurol (2013) 0.86
C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients. J Stroke Cerebrovasc Dis (2013) 0.86
Biomarkers Related to Carotid Intima-Media Thickness and Plaques in Long-Term Survivors of Ischemic Stroke. Transl Stroke Res (2015) 0.85
[Treatment of cerebrovascular disease in a comprehensive stroke unit]. Tidsskr Nor Laegeforen (2011) 0.85
Early supported discharge after stroke in Bergen (ESD Stroke Bergen): a randomized controlled trial comparing rehabilitation in a day unit or in the patients' homes with conventional treatment. Int J Stroke (2012) 0.85
Low body temperature associated with severe ischemic stroke within 6 hours of onset: The Bergen NORSTROKE Study. Vasc Health Risk Manag (2012) 0.85
How accurate are published recurrence rates after rectal prolapse surgery? A meta-analysis of individual patient data. Am J Surg (2006) 0.85
Elevated admission blood pressure and stroke severity in acute ischemic stroke: the Bergen NORSTROKE Study. Cerebrovasc Dis (2013) 0.84
The effect of physiologic derangement in patients with stroke treated with thrombolysis. J Stroke Cerebrovasc Dis (2008) 0.84
Comparison between Ischemic Stroke Patients <50 Years and ≥50 Years Admitted to a Single Centre: The Bergen Stroke Study. Stroke Res Treat (2011) 0.84
Arterial events after ischemic stroke at a young age: a cross-sectional long-term follow-up of patients and controls in western Norway. Cerebrovasc Dis (2007) 0.82
Post-stroke pain on long-term follow-up: the Bergen stroke study. J Neurol (2010) 0.81
[Prostate cancer in Denmark 1943-2002]. Ugeskr Laeger (2007) 0.81
High incidence of infarction in the left cerebral hemisphere among young adults. J Stroke Cerebrovasc Dis (2007) 0.81
Persistent middle cerebral artery occlusion associated with lower body temperature on admission. Vasc Health Risk Manag (2013) 0.81
Spinal Cord Infarction in Clinical Neurology: A Review of Characteristics and Long-Term Prognosis in Comparison to Cerebral Infarction. Eur Neurol (2016) 0.81
Preadmission use of warfarin improves short-term outcome in patients with acute cerebral infarction. The Bergen Stroke Study. Cerebrovasc Dis (2009) 0.80
Microemboli-monitoring during the acute phase of ischemic stroke: is it worth the time? BMC Neurol (2010) 0.79
Leukoaraiosis is associated with short- and long-term mortality in patients with intracerebral hemorrhage. J Stroke Cerebrovasc Dis (2013) 0.78
Combined carotid and transcranial ultrasound findings compared with clinical classification and stroke severity in acute ischemic stroke. Cerebrovasc Dis (2005) 0.78
Long-term effect of intravenous thrombolytic therapy in acute stroke: responder analysis versus uniform analysis of excellent outcome. Cerebrovasc Dis (2005) 0.77
Clinical presentation and diffusion weighted MRI of acute cerebral infarction. The Bergen Stroke Study. BMC Neurol (2009) 0.77
Persistent atrial fibrillation is associated with worse prognosis than paroxysmal atrial fibrillation in acute cerebral infarction. ISRN Cardiol (2012) 0.77
Prevalence and covariates of masked hypertension in ischemic stroke survivors: the Norwegian Stroke in the Young Study. Blood Press Monit (2016) 0.76